By understanding the risks associated with GLP-1 therapy and incorporating solutions such as BIOLYTE into patient care plans, healthcare providers can help patients manage side effects effectively and optimize treatment outcomes
We source only from FDA-registered manufacturers with Certificates of Analysis verifying purity and potency
This case follows a growing number of claims linking GLP-1 receptor agonistssuch as Ozempic, Wegovy, and Mounjaroto NAION
This happens with all kinds of weight loss, not just weight loss on GLP-1 drugs
It should be noted that physiologic GLP-1R agonism in the periphery mediates food intake reduction via vagal afferent signaling as rats with a surgical subdiaphragmatic vagal deafferentation (SDA) exhibit a more mild food intake suppression in response to acute administration of GLP-1 analogues than sham operated animals (80, 81)
Weight regain after stopping GLP-1s is real and still a concern, particularly for people who stop without any follow-up treatment plan
